Benjamin Haynor
Stock Analyst at Lake Street
(1.67)
# 3,271
Out of 5,058 analysts
12
Total ratings
36.36%
Success rate
2.22%
Average return
Main Sectors:
Stocks Rated by Benjamin Haynor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INFU InfuSystem Holdings | Assumes: Buy | $15 | $9.28 | +61.64% | 1 | Sep 22, 2025 | |
| ELMD Electromed | Assumes: Buy | $36 | $25.21 | +42.80% | 1 | Aug 27, 2025 | |
| PROF Profound Medical | Maintains: Buy | $17 → $11 | $6.02 | +82.72% | 1 | Apr 23, 2025 | |
| VSAT Viasat | Maintains: Buy | $31 → $19 | $34.92 | -45.59% | 5 | Sep 20, 2024 | |
| CGNT Cognyte Software | Downgrades: Hold | n/a | $8.03 | - | 2 | Mar 13, 2018 | |
| DRIO DarioHealth | Initiates: Buy | $1,400 | $14.10 | +9,831.19% | 1 | Aug 29, 2017 | |
| SRDX Surmodics | Initiates: Buy | $44 | $42.98 | +1.21% | 1 | Jun 27, 2017 |
InfuSystem Holdings
Sep 22, 2025
Assumes: Buy
Price Target: $15
Current: $9.28
Upside: +61.64%
Electromed
Aug 27, 2025
Assumes: Buy
Price Target: $36
Current: $25.21
Upside: +42.80%
Profound Medical
Apr 23, 2025
Maintains: Buy
Price Target: $17 → $11
Current: $6.02
Upside: +82.72%
Viasat
Sep 20, 2024
Maintains: Buy
Price Target: $31 → $19
Current: $34.92
Upside: -45.59%
Cognyte Software
Mar 13, 2018
Downgrades: Hold
Price Target: n/a
Current: $8.03
Upside: -
DarioHealth
Aug 29, 2017
Initiates: Buy
Price Target: $1,400
Current: $14.10
Upside: +9,831.19%
Surmodics
Jun 27, 2017
Initiates: Buy
Price Target: $44
Current: $42.98
Upside: +1.21%